feed,title,long_url,short_url
Benzinga,"Applied Therapeutics' Investigational Drug Shows Clinical Benefit In Rare Metabolic Disorder, Chalks Out FDA Submission Plans",https://benzinga.com/general/biotech/23/04/31959096/applied-therapeutics-investigational-drug-shows-clinical-benefit-in-rare-metabolic-disorder-chalk,https://da.gd/qGrM6s
Benzinga,"More Trouble For Foghorn Therapeutics: After Blood Cancer Trial, FDA Puts Another Cancer Trial On Clinical Hold",https://benzinga.com/general/biotech/23/04/31956913/more-trouble-for-foghorn-therapeutics-after-blood-cancer-trial-fda-puts-another-cancer-trial-on-c,https://da.gd/dlpOSv
